Dr. Lalezari: Most patients are showing great i
Post# of 148183
(Total Views: 661)
Posted On: 05/13/2020 12:45:40 PM
Dr. Lalezari:
Most patients are showing great improvement by day three... surprising how quickly getting much better
Even as clinical protocols are enrolling we think should be providing compassionate trials
Bruce has shown Rantes levels, patients can still have elevated rantes levels out to day 14... would extend to three doses to cover up to day 14 days and first dose be intravenously administered... will have protocol for the kids (Kawasaki), three doses and first by IV infusion.
Dr. Pourhassan:
Of course would be going through FDA
Protocols being submitted for Compassionate Use this week.
Dr. Patterson:
11 at Montifiore were worst of the worst and all with renal failure... still sustained four of them. Want to show success of the drug is doing what we believe it should be doing... that's the great coordination of response to drug with overall survival with patients... giving credibility to the drug... different than any other drug. They can't link the outcome with a positive result in the lab findings... we know EXACTLY how the drug is working. Trials are enrolling very successfully.
Most patients are showing great improvement by day three... surprising how quickly getting much better
Even as clinical protocols are enrolling we think should be providing compassionate trials
Bruce has shown Rantes levels, patients can still have elevated rantes levels out to day 14... would extend to three doses to cover up to day 14 days and first dose be intravenously administered... will have protocol for the kids (Kawasaki), three doses and first by IV infusion.
Dr. Pourhassan:
Of course would be going through FDA
Protocols being submitted for Compassionate Use this week.
Dr. Patterson:
11 at Montifiore were worst of the worst and all with renal failure... still sustained four of them. Want to show success of the drug is doing what we believe it should be doing... that's the great coordination of response to drug with overall survival with patients... giving credibility to the drug... different than any other drug. They can't link the outcome with a positive result in the lab findings... we know EXACTLY how the drug is working. Trials are enrolling very successfully.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼